Table 3

Comparison of seroprevalence of HHV-8, CMV and EBV between HIV-seronegative healthy blood donors and HIV-AIDS patients in Ghana by age and gender

Patient characteristic

Proportion (%) of HHV-8 seropositives

Proportion (%) of CMV seropositives

Proportion (%) of EBV seropositives

HIV-

HIV+

*P value

HIV-

HIV+

*P value

HIV-

HIV+

*P value

Age group, years

16–25

169/1016 (16.6)

24/37 (64.9)

< 0.001

790/1016 (77.8)

22/37 (59.5)

0.26

182/1016 (17.9)

30/37 (81.1)

< 0.0005

26–35

329/1340 (24.6)

65/90 (72.2)

< 0.005

989/1340 (73.8)

59/90 (65.6)

0.45

63/1340 (4.7)

80/90 (88.9)

< 0.0001

36–45

147/552 (26.6)

45/73 (61.6)

< 0.05

480/552 (87.0)

41/73 (56.2)

0.10

259/552 (46.9)

65/73 (89.0)

< 0.05

46–55

60/200 (30.0)

21/36 (58.3)

< 0.05

138/200 (69.0)

18/36 (50.0)

0.25

94/200 (47.0)

31/36 (86.1)

< 0.05

56–65

72/167 (43.1)

9/14 (64.3)

< 0.05

145/167 (86.8)

8/14 (57.1)

0.12

58/167 (34.7)

12/14 (85.7)

< 0.05

Gender

Male

567/2573 (22.0)

88/140 (62.9)

< 0.005

2033/2573 (79.0)

80/140 (57.1)

0.19

482/2573 (18.7)

122/140 (87.1)

< 0.0005

Female

210/702 (29.9)

76/110 (69.1)

< 0.05

509/702 (72.5)

68/110 (61.8)

0.36

174/702 (24.8)

96/110 (87.3)

< 0.005

Total

777/3275 (23.7)

164/250 (65.6)

< 0.005

2542/3275 (77.6)

148/250 (59.2)

0.24

656/3275 (20.0)

218/250 (87.2)

< 0.001

*Comparison between HIV-seronegative blood donors and HIV-AIDS patients using the chi-square test with Yates correction.

Adjei et al. BMC Infectious Diseases 2008 8:111   doi:10.1186/1471-2334-8-111